Megan Smith
Dodge Communications

CARY, N.C. — December 17, 2013 — Medfusion, a leading provider of patient engagement and practice efficiency software, announced today the appointment of Vern Davenport as equity partner and president of Medfusion.

In this position, Davenport will become a more integral part of the day-to-day operations of the company and will be responsible for ensuring Medfusion continues to evolve and meet the changing needs of the healthcare industry. In addition, Davenport will continue to serve as a member of the board of directors where he will provide a balanced, strategic perspective on the industry and guide Medfusion to be a leader in the healthcare technology field.

“We are pleased to have a healthcare IT expert like Vern join our organization as an equity partner and member of our executive team,” said Steve Malik, CEO and chairman of Medfusion. “Utilizing technology to bring innovation to the changing healthcare market is the ultimate goal at Medfusion and our growing team is now even better positioned to build on the wealth of talent centralized in North Carolina.”

Davenport brings a lifetime of healthcare and healthcare technology experience in operations and transformational change to the role. Most recently, he led Medquist where he managed a turnaround and rebranding effort to M*Modal, resulting in a successful privatization process. Previously, Davenport has served as CEO of Misys Healthcare where he led the merger of the company with Allscripts. He has also served as a strategy consultant to the chairman of Quintiles, and has been an executive in companies such as Kodak Health, Siemens Medical, Shared Medical Solutions and IBM.

Davenport, a native of North Carolina, is committed to local and state organizations where he currently serves as the Chair of the Triangle Heart Association Board and is a member of the Board of Trustees of East Carolina University. He earned a bachelor’s degree in business and an MBA from East Carolina University in Greenville, N.C.

“I am confident that my experience combined with Steve’s product knowledge, exceptional talent for strategy and distinctive vision will offer us the opportunity to enhance our technology to better serve the needs of our current and perspective clients,” said Davenport. “Medfusion has a long-standing tradition of providing the market with the best solutions possible that meet the needs of the market before there is a groundswell behind it. I am excited to help the organization as we move forward with developing cutting-edge technology.”